UPF3A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.232770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.545600E-01
Normal-vs-Stage2
4.587500E-02
Normal-vs-Stage3
9.607600E-02
Normal-vs-Stage4
3.442800E-01
Stage1-vs-Stage2
3.192400E-01
Stage1-vs-Stage3
8.084000E-02
Stage1-vs-Stage4
7.278800E-01
Stage2-vs-Stage3
8.654000E-02
Stage2-vs-Stage4
6.915600E-01
Stage3-vs-Stage4
5.022100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.448390E-01
Normal-vs-AfricanAmerican
3.382000E-01
Normal-vs-Asian
3.587600E-01
Caucasian-vs-AfricanAmerican
9.850600E-01
Caucasian-vs-Asian
2.867400E-01
AfricanAmerican-vs-Asian
6.153800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.668810E-01
Normal-vs-Female
9.634300E-02
Male-vs-Female
7.290800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.947600E-01
Normal-vs-Age(41-60Yrs)
2.183600E-01
Normal-vs-Age(61-80Yrs)
1.085810E-01
Normal-vs-Age(81-100Yrs)
3.985400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.332600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.307800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.294600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.386000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.129800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.316600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.458500E-02
Normal-vs-Daily Drinker
1.081250E-01
Normal-vs-Weekly Drinker
4.028400E-01
Normal-vs-Occasional Drinker
6.208200E-01
Normal-vs-Social Drinker
2.721400E-01
Non Drinker-vs-Daily Drinker
6.326000E-01
Non Drinker-vs-Weekly Drinker
3.021200E-01
Non Drinker-vs-Occasional Drinker
7.093900E-02
Non Drinker-vs-Social Drinker
1.116610E-01
Daily Drinker-vs-Weekly Drinker
6.730200E-01
Daily Drinker-vs-Occasional Drinker
1.341180E-01
Daily Drinker-vs-Social Drinker
3.456800E-01
Weekly Drinker-vs-Occasional Drinker
2.317200E-01
Weekly Drinker-vs-Social Drinker
5.418000E-01
Occasional Drinker-vs-Social Drinker
5.236600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.925800E-02
Normal-vs-Grade 2
4.117600E-03
Normal-vs-Grade 3
7.637500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.324100E-02
Grade 1-vs-Grade 3
6.582100E-02
Grade 1-vs-Grade 4
7.925800E-02
Grade 2-vs-Grade 3
6.986000E-01
Grade 2-vs-Grade 4
4.117600E-03
Grade 3-vs-Grade 4
7.637500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.472820E-01
Normal-vs-NonDiabetic
1.441400E-01
Diabetic-vs-NonDiabetic
3.849200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.827390E-01
Normal-vs-NoPancreatitis
1.337750E-01
Pancreatitis-vs-NoPancreatitis
9.389800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.387800E-01
Normal-vs-N1
5.048100E-02
N0-vs-N1
1.011170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.797600E-01
Normal-vs-TP53-NonMutant
5.358800E-01
TP53-Mutant-vs-TP53-NonMutant
9.232100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
